Docusign for Life Sciences
Accelerate discovery. Simplify compliance.
Bring life-changing therapies to market faster with a trusted platform for secure, compliant, and automated agreement management.
Advance your goals
- Remove friction from your 21 CFR Part 11 compliance
Simplify contracts, approvals and agreements while reducing regulatory risk. Life sciences organizations have been compliantly managing digital agreements with Docusign since 2015.
- Get drugs and devices to market faster without compromising quality
Streamline your processes to accelerate product development and commercialization for drugs and devices.
- Uplevel your customer experience
Enhance your interactions with patients, physicians, researchers and vendors by enabling them to complete agreements in an accessible, secure way.
How do life sciences organizations use Docusign?
Docusign IAM offers a single platform for every agreement that empowers life sciences organizations to transform agreements from bottlenecks to strategic drivers across the entire value chain, accelerating the journey of life-saving therapeutics from R&D to commercialization.
- Research and clinical development
Preclinical and clinical development
Clinical trial enrollment
Regulatory submissions
Investigator onboarding and site initiation
- Manufacturing and quality
GxP document management
SOPs, batch records, and more
Supplier qualification and onboarding
CMO and technology transfer agreements
- Commercial effectiveness
Sales contracting
Market access agreements
HCP engagement and speaker programs
Patient assistance and reimbursement
Ready to modernize your processes?
How life science organizations use Docusign
75% of envelopes completed in less than seven days
"We can have multiple parties post comments, edit and ask questions directly in the document, while tracking changes with a secure, digital audit trail"
Gord KeithTechnical Operations Manager, Thermo FisherDelivers life-saving solutions faster
"Not only did we save time and boost employee productivity, but we also helped the environment."
Dewey PhanDirector of corporate quality, BD97% faster to get final clearance from physicians
"Docusign helps us bring second chances at life in a faster and more compliant way."
Kim SivananthanQuality Assurance Specialist, DKMS USModernize onboarding
"It’s exciting to see all the different things we can do outside the integration we’re currently using"
Daniel TehraniVice President of IT, ScribeAmerica
Life sciences module: boost efficiency and support compliance
Support your compliance with the electronic signature practices set forth in the U.S. Food and Drug Administration’s 21 CFR Part 11.
Our life sciences module has three components: eSignature, SMS authentication, and validation reports.
Featured integrations for life sciences
Extend the impact of your digital investment with digital workflows, authentication and e-signatures with Docusign's integrations with systems you already use.
Docusign for life sciences FAQs
In the life sciences industry, electronic signatures are used to streamline agreements. Pharmaceutical organizations use e-signatures for clinical trial enrollment, supplier contracts and more to accelerate the development and delivery of therapeutics to market. Medical device manufacturers use e-signatures for clinical testing, sales contracts, service agreements and more to accelerate product development and commercialization.
To meet the needs laid out by our cutting-edge life sciences customers, Docusign released a new package of features: the Life Sciences Pro package. It includes the Docusign CFR Part 11 Module, Validator for Life Sciences and SMS Authentication. In the same way that DocuSign was the first to offer Part 11 compliance, we’re the first to bundle features like this together for a new generation of customers.
The Docusign Part 11 module provides a high-availability, high-security and highly customizable solution to maintain compliance with regulations domestically and globally. The module is designed to be incorporated as part of an open system solution, in which there is electronic communication among multiple parties and system access needs to extend to internal and external parties. This module is absolutely critical for any life sciences organization that handles electronic records.Docusign IAM empowers life sciences organizations to transform agreements from bottlenecks to strategic drivers across the entire value chain, accelerating the journey of life-saving therapeutics from R&D into manufacturing and through commercialization. By leveraging a single, extensible platform to manage all end-to-end agreement processes with unparalleled scale and trust, life sciences organizations see a 40% reduction in personnel time per agreement, a 19% reduction in compliance incidents, and a 95% improvement in data quality. Our unmatched ecosystem of 1,000+ integrations and robust APIs enables life sciences organizations to reduce risk, maintain compliance with evolving regulations, and ultimately unleash the power of their agreements for growth, innovation, and efficiency.
Docusign IAM is the agreement platform your business needs
